COCs with estradiol valerate/dienogest vs 17β-estradiol/nomegestrol acetate: effects on metabolism and body composition in menopausal transition women

S. V. Yureneva, Veronika I. Komedina, Sergey Kuznetsov
In: Maturitas · 2023 · vol. 173 , pp. 76–77 · doi:10.1016/j.maturitas.2023.04.033 · W4379644799
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This study investigated the metabolic and body composition effects of combined oral contraceptives containing estradiol valerate/dienogest compared to those with 17β-estradiol/nomegestrol acetate in women undergoing menopause transition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T06:55:54.812037+00:00
unpaywall
last seen: 2026-06-19T06:35:33.578913+00:00
License: CC0 · commercial use OK